MCG
MGRX icon

McCollum Christoferson Group’s Mangoceuticals MGRX Stock Holding History

McCollum Christoferson Group’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,720
Closed -$20.2K – 73
2024
Q3 		$20.2K Buy
+5,720
New +$27K 0.01% 68
2024
Q2 		– Sell
-2,847
Closed -$9.26K – 72
2024
Q1 		$9.26K Buy
2,847
+1,000
+54% +$3.98K ﹤0.01% 64
2023
Q4 		$7.67K Buy
1,847
+1,094
+145% +$9.69K ﹤0.01% 64
2023
Q3 		$9.61K Buy
+753
New +$14.1K ﹤0.01% 68

Other funds holding MGRX

ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

McCollum Christoferson Group's MGRX Position: Q4 2024 in Review

McCollum Christoferson Group sold out of Mangoceuticals (MGRX) in Q4 2024, closing a stake of 5,720 shares — an estimated $20.2K sold.

McCollum Christoferson Group first reported a position in MGRX in Q3 2023 and held it in 4 quarters. The position peaked at $20.2K in Q3 2024. 9 funds tracked by Wall St. Rank hold MGRX as of Q4 2024.

  • McCollum Christoferson Group reported no remaining Mangoceuticals position as of Q4 2024 after selling out during the quarter.
  • McCollum Christoferson Group sold 5,720 Mangoceuticals shares in Q4 2024, an estimated $20.2K.
  • McCollum Christoferson Group first reported a position in Mangoceuticals in Q3 2023 and held it in 4 quarters.
  • McCollum Christoferson Group's Mangoceuticals position peaked at $20.2K in Q3 2024.
  • 9 funds tracked by Wall St. Rank held Mangoceuticals as of Q4 2024.

Based on McCollum Christoferson Group's 13F filing for Q4 2024, filed 11 Feb 2025.